OCULAR THERAPEUTIX, INC Quarterly Interest Expense in USD from Q2 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Ocular Therapeutix, Inc quarterly/annual Interest Expense history and growth rate from Q2 2013 to Q1 2024.
  • Ocular Therapeutix, Inc Interest Expense for the quarter ending March 31, 2024 was $4.05M, a 129% increase year-over-year.
  • Ocular Therapeutix, Inc Interest Expense for the twelve months ending March 31, 2024 was $13.6M, a 91.7% increase year-over-year.
  • Ocular Therapeutix, Inc annual Interest Expense for 2023 was $11.3M, a 61.5% increase from 2022.
  • Ocular Therapeutix, Inc annual Interest Expense for 2022 was $7.02M, a 5.26% increase from 2021.
  • Ocular Therapeutix, Inc annual Interest Expense for 2021 was $6.67M, a 1.43% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.6M $4.05M +$2.28M +129% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $11.3M $4.15M +$2.31M +125% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $9.03M $3.43M +$1.63M +90.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $7.4M $1.99M +$295K +17.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $7.11M $1.77M +$85K +5.05% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $7.02M $1.85M +$167K +9.95% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $6.86M $1.8M +$139K +8.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $6.72M $1.7M +$41K +2.48% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $6.68M $1.68M +$4K +0.24% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $6.67M $1.68M -$47K -2.72% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $6.72M $1.66M -$57K -3.32% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $6.78M $1.66M -$39K -2.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $6.81M $1.68M +$46K +2.82% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $6.77M $1.73M -$79K -4.38% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $6.85M $1.72M +$64K +3.88% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $6.78M $1.69M +$67K +4.12% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $6.72M $1.63M +$615K +60.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $6.1M $1.81M +$1.43M +383% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $4.67M $1.65M +$1.23M +289% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.44M $1.63M +$1.17M +258% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $2.27M $1.02M +$532K +109% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.74M $374K -$116K -23.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $1.86M $424K -$67K -13.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.92M $455K -$13K -2.78% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.94M $486K +$43K +9.71% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $1.89M $490K +$72K +17.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $1.82M $491K +$65K +15.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.76M $468K +$50K +12% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.71M $443K +$25K +5.98% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.68M $418K +$10K +2.45% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $1.67M $426K +$20K +4.93% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.65M $418K +$13K +3.21% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.64M $418K -$87K -17.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $1.72M $408K +$1K +0.25% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $1.72M $406K -$6K -1.46% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.73M $405K +$148K +57.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.58M $505K +$462K +1074% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.12M $407K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $412K +$318K +338% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $257K +$150K +140% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $43K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 $94K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $107K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.